Volume 5, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Erythromycin was found of value in the treatment of acute amebic dysentery. The drug was given to ten cases in a dose of 1.2 gm. daily for a period of 10 days and in a similar dose to another group for a period of 5 days. Marked improvement appeared in both groups, but two cases relapsed in the second group, while no relapses occurred in the first. The follow up is not complete however, as it was continued only for an average of 3 months. It is suggested that further trials be made, with a longer period of observation.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error